COVID-19 Daily - September 27, 2021: Portugal announces lifting of all restrictions, WHO supports antibody treatment; Less than 4% of Africans have been immunized
The COVID-19 pandemic is far from over. The global evolution is sinusoidal. While in some countries the number of cases is increasing rapidly (see the case of Romania), in others the situation is much better due to the restrictions imposed. During all this time, health professionals have experimented with all kinds of anti-covid treatments, but have also developed new variants of vaccines. Below you have some of the most important information about COVID-19:
- The World Health Organization (WHO) has recommended the use of antibody therapy, called Ronapreve or REGEN-VOC, for high-risk patients. hospitalization and severe forms. The antibody cocktail was used in the treatment of former US President Donald Trump. It is currently being examined by European authorities, while the United Kingdom gave it the green light last month and the Americans approved it for emergency use. The WHO also called on the company to reduce the price of antibody treatment and make it available to everyone fairly.
Portugal will lift all remaining restrictions on 1 October. The announcement was made on Thursday by Prime Minister Antonio Costa. Restaurants, theaters, cinemas, etc. they will be able to receive at full capacity.
- A 12-year-old man from the Netherlands has applied to the court for the right to receive the vaccine, despite his father's objections. The young man wanted to visit his dying grandmother. In the Netherlands, children between the ages of 12 and 17 can choose to be vaccinated, but they need parental permission. If the parents do not agree, Dutch law says that judges can make decisions in the best interests of the children.
- Due to the COVID-19 pandemic, Nobel Prize winners for science and literature will receive their prizes in their home country, not in Sweden as originally planned.
- Less than 4% of people in Africa have been completely vaccinated. This is because there are not enough doses of vaccine. To date, most vaccine doses have arrived in financially powerful, rich and very rich countries. Less than 1% went to low-income countries, according to South African President Cyril Ramaphosa.
- Novavax has asked the WHO for approval of the emergency vaccine. Approval could facilitate the transport of millions of doses to many poorer countries.